These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36183437)

  • 1. Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer.
    Lin Y; Zhang L; Ding X; Chen C; Meng M; Ke Y; Wang W
    Pathol Res Pract; 2022 Nov; 239():154093. PubMed ID: 36183437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
    Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1.
    Zhang J; Li J; Li S; Zhou C; Qin Y; Li X
    Int J Oncol; 2019 Jun; 54(6):2211-2221. PubMed ID: 30942425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.
    Li J; You T; Jing J
    Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer.
    Akbarzadeh M; Mihanfar A; Akbarzadeh S; Yousefi B; Majidinia M
    Life Sci; 2021 Nov; 285():119984. PubMed ID: 34592229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PI3K/Akt/mTOR signaling pathway and non-small cell lung cancer].
    QI H; FAN L
    Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1149-54. PubMed ID: 21159253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway.
    Zheng R; Jiang H; Li J; Liu X; Xu H
    Curr Cancer Drug Targets; 2017; 17(4):376-385. PubMed ID: 28093061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach.
    Gulhane P; Nimsarkar P; Kharat K; Singh S
    Oncotarget; 2022; 13():725-746. PubMed ID: 35634241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
    Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed role of microRNA-mediated regulation of PI3K/AKT axis in human tumors.
    Al-Hawary SIS; Ruzibakieva M; Gupta R; Malviya J; Toama MA; Hjazi A; Alkhayyat MRR; Alsaab HO; Hadi A; Alwaily ER
    Cell Biochem Funct; 2024 Jan; 42(1):e3904. PubMed ID: 38102946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.
    Moafian Z; Maghrouni A; Soltani A; Hashemy SI
    Mol Biol Rep; 2021 May; 48(5):4797-4811. PubMed ID: 34057685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer.
    Jian M; Yunjia Z; Zhiying D; Yanduo J; Guocheng J
    Mol Carcinog; 2019 Mar; 58(3):358-365. PubMed ID: 30362635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.
    Zito CR; Jilaveanu LB; Anagnostou V; Rimm D; Bepler G; Maira SM; Hackl W; Camp R; Kluger HM; Chao HH
    PLoS One; 2012; 7(2):e31331. PubMed ID: 22355357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.